Education/ACR/EULAR

EULAR and the Paediatric Rheumatology European Society (PReS) and FDA now view systemic juvenile idiopathic arthritis and adult-onset Still’s disease as a single entity — Still’s disease; based on overlapping tests, clinical manifestations, complications & response to biologics… https://t.co/OHfcFymdPx https://t.co/Wm2ciKbMtY
Dr. John Cush @RheumNow( View Tweet )
AI

Will the Robots Save Ultrasound?

David Liew, FRACP

Despite all its benefits, ultrasound’s daily clinical use remains the domain of only a subset of interested rheumatologists. If the benefits are so clear, then why is it not universal? In the late-breaking oral abstracts at ACR Convergence, the final abstract presentation was from the Danish

Read Article
ACR24 RA Topic Panel: Innovations in Rheumatoid Arthritis https://t.co/dHiRacDmWc

Links:

Dr. John Cush @RheumNow( View Tweet )

ACR24 PsA Topic Panel Advancing Care for Psoriatic Arthritis Tune in for an engaging discussion at the ACR Annual Meeting! This expert panel will explore the latest breakthroughs and trends in Psoriatic Arthritis(PsA) research and management, providing actionable insights for… https://t.co/j0063RpVCi https://t.co/LCINZvUR5s
Dr. John Cush @RheumNow( View Tweet )
Standardizing Still’s Disease Research: Global Data Harmonization Needed A recent study presented at #ACR24 convergence highlights significant gaps and inconsistencies in the research of systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still’s disease (AOSD).… https://t.co/ugsfRj2fnS https://t.co/UJmNvAMo1c
Dr. John Cush @RheumNow( View Tweet )
ACR24 SpA Panel: Key Discussions on Spondyloarthritis Join panelists Dr. Sheila Reyes, Dr. Adela Castro, Dr. Lihi Eder and Dr. Marina Magrey as they discuss key highlights and takeaways on spondyloarthritis sessions and abstracts presented at the 2024 ACR meeting in Washington,… https://t.co/XGcR6WDBFO https://t.co/0mJ08nheJJ
Dr. John Cush @RheumNow( View Tweet )
Why should rheumatologists care about aging? As a herald to what was to come in Washington, the publication of the Lancet Rheumatology series on aging coming just days before #ACR24 set the stage for the “grey tsunami” of geriatric rheumatology that was to follow.… https://t.co/XfB7ykV0Xs https://t.co/51Cjz3EGyn
Dr. John Cush @RheumNow( View Tweet )
Roundup cover

ACR24: Rheumatology Roundup

Jack Cush, MD

Join Drs. Jack Cush and Artie Kavanaugh as they review 15+ presentations and abstracts from the 2024 ACR Convergence meeting in Washington, DC.

Read Article
CAR-T

ICYMI: Taking CAR-T for a Test Drive

Michael Putman, MD, MSCI

When the ACR Convergence 2024 abstract site went live, the first query I typed into the search bar was, “CAR-T.” I consider myself a CAR-T skeptic and would be surprised if the magical results from this NEJM case series replicate at scale, but it seems likely that CAR-T will

Read Article
RA-ILD in the Spotlight at #ACR24 Over the past 5 years, there has been growing interest in RA-ILD due to its relative prevalence and severity. This seems to be one of the few RA outcomes not improving much, even with the advent of expanded treatment options.… https://t.co/MIPXW9EgVa https://t.co/kX0hDq8NTH
Dr. John Cush @RheumNow( View Tweet )
The Case for JAKi in PMR Dr. David Liew abstract 0858, Baricitinib in Early Polymyalgia Rheumatica (BACHELOR Study), presented at #ACR24. https://t.co/NLF75PuMOb https://t.co/FpUUdbtrwf

Links:

Dr. John Cush @RheumNow( View Tweet )
What Lies Beneath: Understanding Nailfold Capillaroscopy Capillaroscopy is a non-invasive imaging technique used for the in vivo assessment of the microcirculation. It can be performed using various optical instruments, but only the dermatoscope and videocapillaroscope have… https://t.co/JK9EvuxWEV https://t.co/77AcwfKIzE
Dr. John Cush @RheumNow( View Tweet )
ANA+ and no Autoimmune Disease? Check the liver Dr. Janet Pope discusses abstract 0627, presented at #ACR24. https://t.co/4HV2kqjibL https://t.co/kmVcvUZtRQ

Links:

Dr. John Cush @RheumNow( View Tweet )
#ACR Best 2024 - Day 4 Although the last day of #ACR24 was but a half day - it was chock full of gems, many coming from the late breaking abstracts presented today. As chosen by the RheumNow faculty, here are some highlight presentations you need to know about.… https://t.co/GseDW1ZfkL https://t.co/35aJs0yG8i
Dr. John Cush @RheumNow( View Tweet )
The Psoriatic March: PsA before PsO https://t.co/lRCrzdKX7Z https://t.co/eabYe3GXrM

Links:

Dr. John Cush @RheumNow( View Tweet )
Worried about CV Risk and JAKi? What about the Steroids? Dr. David Liew discusses abstracts 1981 and 2673, presented at #ACR24 https://t.co/OkMgIqxl2A https://t.co/1DVapGcWUn

Links:

Dr. John Cush @RheumNow( View Tweet )
obese.waist_.jpg

Ozempic will change rheumatology

David Liew, FRACP

Many of our diseases are made worse by obesity, notably rheumatoid arthritis, psoriatic arthritis, and osteoarthritis. Much of the refractory pain and suffering from these conditions might be attributable to obesity, so active questions will be raised about how GLP-1 agonists can influence the

Read Article
light-bulbs-1125016_640.jpg

Off-Label Use of JAK Inhibitors in Orphan Diseases and Other Conditions?

Janet Pope, MD, MPH, FRCPC

When should you consider off-label use of JAKi?

Read Article
#ACR24: What I learned in Sjogren's, Takayasu's and CAR-T Dr. Janet Pope reviews abstract 2527 and abstract 1696. https://t.co/rrrGnOhfIV https://t.co/Ht1UTtYOLI

Links:

Dr. John Cush @RheumNow( View Tweet )
What's New in Relapsing Polychondritis? Dr. Bella Mehta discusses abstract 2649 presented at #ACR24. https://t.co/4ibGOFzTAG https://t.co/fnvp1m1nS8

Links:

Dr. John Cush @RheumNow( View Tweet )
A useful urinary biomarker for lupus nephritis Dr. Andrea Fava discusses plenary abstract 1642, presented at #ACR24 https://t.co/5kFXUn3xlF https://t.co/mWTX9SbDGm

Links:

Dr. John Cush @RheumNow( View Tweet )
Is Frequent Lab Monitoring Necessary? Dr. Bella Mehta discusses abstract 2619, Safety Outcomes of Routine Blood Tests for Monitoring of Biologic and Targeted Synthetic Therapies in Inflammatory Arthritis Patients, presented at #ACR24. https://t.co/vwPueeAVhO https://t.co/5wyTahjMAu

Links:

Dr. John Cush @RheumNow( View Tweet )
Stills,continuum

​​Standardizing Still’s Disease Research: Global Data Harmonization Needed

Bella Mehta, MBBS, MS

A recent study presented at #ACR24 convergence highlights significant gaps and inconsistencies in the research of systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still’s disease (AOSD). Analyzing 195 studies with over 18,000 patients, they found considerable variation

Read Article
#ACR24 BEST Abstracts from Day 3 https://t.co/CQ3FxPKfxQ https://t.co/aIQdDhYYMj

Links:

Dr. John Cush @RheumNow( View Tweet )
Anti IL-17 on Entheseal Biopsy in PsA Dr. Eric Dein reports on abstract 2586, presented at #ACR24 https://t.co/2JCFnB8HNq https://t.co/2MFCiNnvj2

Links:

Dr. John Cush @RheumNow( View Tweet )

Recent Blogs

The EHR is Down! $@&#!

Jack Cush, MD
Cush EHR is Down Still

The advantage to patient care without the crutch of an EHR. What do you do?

Read Post

Gangsin: 갱신 Korean: refresh, renew, updated

Kathryn H. Dao, M.D.
change,future,lens,clarity
Remaining status quo requires less effort than making a change. Over the last 20+ years, I have listened to thousands of patients confide their personal stories. Some remained paralyzed in their current state of distress, fearing new situations may be worse. I was one of them, until recently. In this final blog of my trilogy on self-discovery, I reveal my new life. Read Post

Featured Video

Do you get our email newsletter?

Looking for the latest rheumatology news & trends? Sign up for the RheumNow weekday newsletter:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rheumnow.com is a news source dedicated to the field of Rheumatology. It is written by experts in the field, and written for rheumatologists and individuals working in related fields. Rheumnow.com provides daily updates on the site and in your inbox when you are signed up for our newsletter.

Copyright 2024 All Rights Reserved.

×